BUY MBP RETEPLASE RETELEX KIT 18MG VIAL BEST PRICE ONLINE IN NIGERIA LAGOS ABUJA KANO AND PORTHARCOURT AT MYBIGPHARMACY.COM

Description

Dear friend, this medication requires a prescription or medical license before it can be delivered to you. kindly ensure that you provide us with a reliable contact information at checkout, mybigpharmacy team will be in touch with you to obtain required document before your order is confirmed thank you for trusting mybig pharmacy with your health. Reteplase is a thrombolytic medicine used to dissolve blood clots that block blood flow in the body. It is most commonly used in the emergency treatment of acute myocardial infarction, also known as a heart attack. Reteplase works by restoring blood flow to the heart muscle, helping to reduce heart damage and improve survival when given as early as possible after symptoms begin.

Reteplase is a genetically engineered form of tissue plasminogen activator. It works by converting plasminogen into plasmin, an enzyme that breaks down fibrin, which is the main structural component of blood clots. By breaking down the clot, reteplase helps reopen blocked blood vessels and restore oxygen supply to affected tissues. Unlike some older clot-busting drugs, reteplase has a simplified structure that allows it to be given as a rapid injection rather than a long infusion.

Reteplase is given by injection into a vein, usually as two separate intravenous bolus doses given 30 minutes apart. It is administered in a hospital or emergency setting under strict medical supervision. Because of its powerful clot-dissolving effect, continuous monitoring of heart rhythm, blood pressure, oxygen levels, and signs of bleeding is essential during and after administration.

The main benefit of reteplase is its ability to rapidly restore blood flow in patients experiencing a heart attack caused by a blocked coronary artery. Early treatment significantly reduces heart muscle damage and improves survival outcomes. Reteplase is most effective when given within the first few hours after symptoms begin, ideally within 12 hours of chest pain onset.

The most important risk associated with reteplase is bleeding. Because it breaks down clots throughout the body, it can cause bleeding at injection sites, in the gastrointestinal tract, or internally. Serious bleeding such as intracranial haemorrhage, although rare, can be life-threatening. For this reason, careful patient selection is essential before giving reteplase.

Patients who should not receive reteplase include those with active internal bleeding, a history of haemorrhagic stroke, recent major surgery or trauma, severe uncontrolled high blood pressure, or known bleeding disorders. Caution is also required in elderly patients and those with low body weight, as the risk of bleeding may be higher.

Other possible side effects of reteplase include low blood pressure, allergic reactions, fever, nausea, and irregular heart rhythms, especially when blood flow returns to the heart. These heart rhythm changes are often temporary and may actually indicate successful reopening of the blocked artery.

Reteplase is often used together with other medications such as aspirin, heparin, or antiplatelet drugs to improve outcomes and prevent new clots from forming. Close monitoring in a coronary care unit is standard practice after administration.

After receiving reteplase, patients are carefully observed for signs of bleeding, neurological changes, or recurrence of chest pain. Follow-up treatment usually includes long-term medications such as antiplatelets, statins, beta blockers, and lifestyle modifications to reduce future cardiovascular risk.

In summary, reteplase is a powerful clot-dissolving medicine used in emergency cardiac care to restore blood flow during a heart attack. When given promptly and appropriately, it significantly improves survival and limits heart damage. However, because of its strong effect on blood clotting, it must be used under strict medical supervision with careful monitoring for bleeding and other complications.